Hepatocarcinoma

Hepatocarcinoma

El hepatocarcinoma es un tumor con una incidencia creciente y representa la tercera causa de muerte por cáncer a nivel mundial. Presenta variaciones geográficas importantes y está relacionado con múltiples factores ambientales. La intervención sobre estos factores puede modificar su incidencia y su...

Full description

Bibliographic Details
Main Authors:	Iván Nieto, Freddy Alcarraz, Gregorio Santana
Format:	Article
Language:	Spanish
Published:	Sociedad de Lucha contra el Cáncer-SOLCA 2007-12-01
Series:	Oncología
Subjects:	Hepatocarcinoma inhibidores de las tirosina quinasas
Online Access:	https://roe-solca.ec/index.php/johs/article/view/411

Similar Items

Derrame pericárdico con inminente taponamiento cardiaco secundario a inhibidor de la tirosina quinasa. Reporte de un caso
by: Andrés F. Buitrago, MD, et al.
Published: (2011-03-01)

Determinación de la mutación V617F del gen JAK2 en los síndromes mieloproliferativos crónicos en nuestro país
by: Daniela Lens, et al.
Published: (2007-06-01)

Factores de crecimiento IV: Factor de crecimiento epidérmico,Factores estimuladores de colonias, Neurotropinas Growth factors: epidermal growth factor, colony stimulating factors and neurotropins
by: Hilda Norha Jaramillo Londoño, et al.
Published: (1999-02-01)

Derrame pericárdico con inminente taponamiento cardiaco secundario a inhibidor de la tirosina quinasa: Reporte de un caso Pericardial effusion secondary to tyrosine kinase inhibitor with imminence of cardiac tamponade: case report
by: Andrés F Buitrago, et al.
Published: (2011-04-01)

Nuevos conceptos sobre hepatocarcinoma
by: Cecilia Abarca, et al.
Published: (2022-04-01)

Estudio de los polimorfismos L858R y G719S del dominio tirosina quinasa del receptor del factor de crecimiento epidermal (EGFR) en individuos de la población ecuatoriana afectos de cáncer pulmonar
by: Andrés López Cortés, et al.
Published: (2007-12-01)

Utilidad clínica de la biopsia líquida para el diagnóstico y seguimiento de los pacientes con CPNM y EML4-ALK
by: Sánchez-Herrero Estela, et al.
Published: (2020-03-01)

Ruptura espontánea de un Hepatocarcinoma
by: Germán Reyes, et al.
Published: (2007-06-01)

Hepatocarcinoma: estado actual
Published: (2014-12-01)

Hepatocarcinoma: from pathogenic mechanisms to target therapy
by: Luigi Manzione, et al.
Published: (2011-12-01)

Hepatocarcinoma fibrolamelar
by: Martín Ferreira Pozzi, et al.
Published: (2020-04-01)

Agammaglobulinemia ligada al X o de Bruton: Aspectos clínicos, moleculares y terapéuticos Bruton or X-linked agammablobulinemia: Clinical, molecular and therapeutic aspects
by: Vianed Marsán Suárez
Published: (2001-12-01)

Inestabilidad Cromosómica Inducida por el Inhibidor de la Proteína Quinasa Aurora A
by: Ana Maritza Erazo Milla
Published: (2014-12-01)

Tumores estromales gastrointestinales. Una visión actual
by: Lázaro Antonio Arango Molano, et al.
Published: (2006-09-01)

Combinación poco habitual de hepatocarcinoma con síndrome de Sjögren
by: Urbano Solís Cartas, et al.
Published: (2018-07-01)

Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models
by: Hijona Elizabeth, et al.
Published: (2012-02-01)

Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells
by: María José López-Grueso, et al.
Published: (2019-10-01)

Inhibidores de la tirosina-cinasa en cáncer de tiroides
by: A. Román-González, et al.
Published: (2021-03-01)

Inhibidores de Janus Quinasas, consideraciones actuales
by: Sara Viviana Vargas López
Published: (2022-06-01)

Intestinal Intervention Strategy Targeting Myeloid Cells to Improve Hepatic Immunity during Hepatocarcinoma Development
by: Adrián Bouzas Muñoz, et al.
Published: (2021-11-01)

Avances en tumores del estroma gastrointestinal: ¿hacia dónde vamos?
by: Juan A. Fernández-Hernández, et al.
Published: (2022-04-01)

Sodium Valproate Induces Cell Senescence in Human Hepatocarcinoma Cells
by: Hong-Mei An, et al.
Published: (2013-12-01)

Polyditerpene acid from Pinus koraiensis pinecones inhibits the progression of hepatocarcinoma
by: Chao Xin, et al.
Published: (2021-04-01)

Hepatocarcinoma: Evaluación con tomografía computada luego del tratamiento intervencionista Hepatocellular carcinoma: computed tomography assessment after invasive treatment
by: Shigeru Kozima, et al.
Published: (2008-12-01)

Hepatocarcinoma: estudio epidemiológico en la policlínica de Hepatología del Hospital Pasteur entre 2007-2016
by: Valentina Berrutti, et al.
Published: (2018-09-01)

Synthesis and Anti-Hepatocarcinoma Effect of Amino Acid Derivatives of Pyxinol and Ocotillol
by: Ying Zhang, et al.
Published: (2021-02-01)

Identification of matrix metalloproteinases secreted by human hepatocarcinoma HepG2 cells
by: Young Jae Lee, et al.
Published: (2022-03-01)

Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma
by: Kaio Murilo Monteiro Espíndola, et al.
Published: (2019-06-01)

Masculino de 86 años con masa intra abdominal: tumor del estroma gastrointestinal
by: Irene Mora Quesada, et al.
Published: (2015-02-01)

Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib
by: Flavia Fondevila, et al.
Published: (2021-10-01)

All-trans retinoic acid inhibits the malignant behaviors of hepatocarcinoma cells by regulating ferroptosis
by: Yanting Sun, et al.
Published: (2022-11-01)

Mesohepatectomía, una alternativa para el manejo del hepatocarcinoma en paciente no cirrótico: serie de casos
by: Luis Manuel Barrera-Lozano, et al.
Published: (2021-11-01)

Diabetes inducida por medicamentos: toxicidad por uso de inhibidor de PI3Kα (Alpelisib)
by: Blanca Azucena Infante Camacho, et al.
Published: (2023-12-01)

Diabetes inducida por medicamentos: toxicidad por uso de inhibidor de PI3Kα (Alpelisib)
by: Blanca Azucena Infante Camacho, et al.
Published: (2023-12-01)

Anticancer Peptide fromChinese Toad (Bufo Bufo Gargarizans) Skin Enhanced Sensitivity to 5-Fu in Hepatocarcinoma cells (HepG2)
by: Chuang-xin LU, et al.
Published: (2011-09-01)

Correlación de los niveles de alfafetoproteína sérica preoperatoria y sobrevida en el tratamiento quirúrgico del hepatocarcinoma en una unidad médica de alta especialidad en Veracruz, México
by: G. Martínez-Mier, et al.
Published: (2017-10-01)

Major Hepatectomy En Bloc with Cava Vein Resection for Locally Invasive Caudate Lobe Hepatocarcinoma
by: Nicolae Bacalbasa, et al.
Published: (2021-10-01)

Hepatitis C and hepatocellular carcinoma
by: Eduardo Fassio
Published: (2010-01-01)

C3G Is Upregulated in Hepatocarcinoma, Contributing to Tumor Growth and Progression and to HGF/MET Pathway Activation
by: Celia Sequera, et al.
Published: (2020-08-01)

Successful treatment with blinatumomab for acute lymphoblastic leukemia in an older adult patient complicated with hepatocarcinoma
by: Masuho Saburi, et al.
Published: (2024-01-01)